doxorubicin ebewe 2 mg/ml concetrate for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Доксорубицин - 2 mg/ml concetrate for solution for infusion
etoposide ebewe 20 mg/ml concentrate for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Этопозид - 20 mg/ml concentrate for solution for infusion
mitoxantron ebewe 2 mg/ml concentrate for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Митоксантрон - 2 mg/ml concentrate for solution for infusion
paclitaxel ebewe 6 mg/ml concentrate for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Паклитаксел - 6 mg/ml concentrate for solution for infusion
alexan 100 mg/5 ml solution for injection
ebewe pharma ges.m.b.h. nfg.kg - Цитарабин - 100 mg/5 ml solution for injection
alexan 50 mg/ml solution for injection
ebewe pharma ges.m.b.h. nfg.kg - Цитарабин - 50 mg/ml solution for injection
gemsol 40 mg/ml concentrate for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - 40 mg/ml concentrate for solution for infusion
ebetrexat 10 mg/ml solution for injection in pre - filled syringe
ebewe pharma ges.m.b.h. nfg.kg - 10 mg/ml solution for injection in pre - filled syringe
ebetrexat 20 mg/ml solution for injection in pre - filled syringe
ebewe pharma ges.m.b.h. nfg.kg - Метотрексат - 20 mg/ml solution for injection in pre - filled syringe
atriance
sandoz pharmaceuticals d.d. - неларабин - Прекурсорна Т-клетъчна лимфобластна левкемия-лимфом - Антинеопластични средства - nelarabine е показан за лечение на пациентите с т-клетъчен остър лимфобластным левкемия (Т-ол) и т-клетъчна лимфоцитна лимфом (Т-ЛБЛ), чието заболяване не се отговаря, или се е появил рецидив след лечение с най-малко два режима на химиотерапия. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.